Trindade Musskopf*
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The increasing prevalence of diabetes worldwide poses significant challenges to healthcare systems. According to the International Diabetes Federation (IDF), approximately 537 million adults were living with diabetes in 2021, a number projected to rise to 643 million by 2030. This review article examines current trends in the management and treatment of diabetes mellitus, highlighting advancements in pharmacological therapies, lifestyle interventions, and technology Type 1 Diabetes (T1D): An autoimmune condition leading to the destruction of insulin-producing beta cells in the pancreas. It typically manifests in childhood or adolescence but can occur at any age. Type 2 Diabetes (T2D): The most common form, characterized by insulin resistance and relative insulin deficiency. T2D is often associated with obesity, sedentary lifestyle, and genetic factors. It typically presents in adults but is increasingly diagnosed in children and adolescents due to rising obesity rates [1]
PDFShare this article
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report
